Published in Can Fam Physician on March 01, 2010
Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol (2006) 2.80
Essential tremor. Lancet Neurol (2005) 2.64
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2005) 2.16
What is moderate drinking? Defining "drinks" and drinking levels. Alcohol Res Health (1999) 1.82
A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord (2007) 1.54
The effect of levetiracetam on essential tremor. Neurology (2005) 1.26
Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry (1985) 1.17
Disability in essential tremor: effect of treatment. Neurology (1986) 1.11
Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord (2000) 1.07
A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol (1999) 1.05
A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology (2002) 1.04
A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry (1986) 1.02
Pharmacotherapy of essential tremor : an overview of existing and upcoming agents. CNS Drugs (2008) 1.01
Double-blind controlled trial of gabapentin in essential tremor. Mov Disord (1998) 0.97
Double-blind comparison of primidone and phenobarbital in essential tremor. Neurology (1988) 0.96
Gabapentin abuse in inmates with prior history of cocaine dependence. Am J Addict (2004) 0.91
Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials. Clin Neuropharmacol (2008) 0.91
Propranolol therapy for essential tremor of the head. Neurology (1984) 0.87
Essential tremor. Clin Geriatr Med (2006) 0.86
Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up. Parkinsonism Relat Disord (2003) 0.85
Quantitative comparison of barbiturates in essential hand and head tremor. Mov Disord (1991) 0.80
Opioids for chronic noncancer pain in the elderly: an osteoarthritis case. Can Fam Physician (2011) 0.88
Rate versus rhythm control in atrial fibrillation. Can Fam Physician (2013) 0.86
Taking the stress out of acne management. Can Fam Physician (2009) 0.83
A brief overview of academic detailing in Canada: Another role for pharmacists. Can Pharm J (Ott) (2012) 0.82
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure. Ann Intern Med (2005) 0.78
Behaviour management in dementia. Can Fam Physician (2011) 0.77
Diabetes in the frail elderly: individualization of glycemic management. Can Fam Physician (2012) 0.77
Taking the stress out of individualizing ADHD drug therapy. Can Fam Physician (2009) 0.75
Targeting success in heart failure: evidence-based management. Can Fam Physician (2010) 0.75
Taking the stress out of treating erectile dysfunction. Can Fam Physician (2010) 0.75
Taking the stress out of insulin initiation in type 2 diabetes mellitus. Can Fam Physician (2009) 0.75
Navigating the complexity of ulcerative colitis: challenging case example. Can Fam Physician (2011) 0.75
Approach to the management of idiopathic hirsutism. Can Fam Physician (2012) 0.75
Taking the stress out of managing gout. Can Fam Physician (2009) 0.75
Funding for continuing medical education. CMAJ (2008) 0.75
Drug comparison charts. Detailed, objective, comparative drug information. Can Fam Physician (2004) 0.75